0000950170-24-079035.txt : 20240628
0000950170-24-079035.hdr.sgml : 20240628
20240628160504
ACCESSION NUMBER: 0000950170-24-079035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240627
FILED AS OF DATE: 20240628
DATE AS OF CHANGE: 20240628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silverman Peter B.
CENTRAL INDEX KEY: 0001790314
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 241085614
MAIL ADDRESS:
STREET 1: C/O MERUS N.V.
STREET 2: YALELAAN 62
CITY: UTRECHT
STATE: P7
ZIP: 3584 CM
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
4
1
ownership.xml
4
X0508
4
2024-06-27
0001651311
Merus N.V.
MRUS
0001790314
Silverman Peter B.
C/O MERUS N.V.
UPPSALALAAN 17
UTRECHT
P7
3584 CT
NETHERLANDS
false
true
false
false
COO & GC
true
Common Shares
2024-06-27
4
M
false
2547
17.94
A
2547
D
Common Shares
2024-06-27
4
M
false
7453
17.94
A
10000
D
Common Shares
2024-06-27
4
S
false
10000
60.0000
D
0
D
Share Option (right to buy)
17.94
2024-06-27
4
M
false
2547
0
D
2028-02-21
Common Shares
2547
0
D
Share Option (right to buy)
17.94
2024-06-27
4
M
false
7453
0
D
2028-02-21
Common Shares
7453
0
D
These transactions were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 15, 2024.
The options is fully vested and exercisable.
/s/ Peter Silverman as attorney-in-fact
2024-06-28